BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18313983)

  • 1. Can B-type natriuretic peptides replace heart failure risk models?
    Levy WC
    Eur J Heart Fail; 2008 Mar; 10(3):224-5. PubMed ID: 18313983
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients.
    Pfister R; Diedrichs H; Schiedermair A; Rosenkranz S; Hellmich M; Erdmann E; Schneider CA
    Eur J Heart Fail; 2008 Mar; 10(3):315-20. PubMed ID: 18304872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
    Daly MG; Frampton CM; Troughton RW
    J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.
    Hogenhuis J; Voors AA; Jaarsma T; Hoes AW; Hillege HL; Kragten JA; van Veldhuisen DJ
    Eur J Heart Fail; 2007 Aug; 9(8):787-94. PubMed ID: 17532262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure.
    Gardner RS; Chong KS; Morton JJ; McDonagh TA
    Eur J Heart Fail; 2007 Mar; 9(3):266-71. PubMed ID: 17023207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide.
    Hülsmann M; Berger R; Mörtl D; Gore O; Meyer B; Pacher R
    Eur J Heart Fail; 2005 Jun; 7(4):552-6. PubMed ID: 15921794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NT-proBNP assay identifies very elderly nursing home residents suffering from pre-clinical heart failure.
    Valle R; Aspromonte N; Barro S; Canali C; Carbonieri E; Ceci V; Chinellato M; Gallo G; Giovinazzo P; Ricci R; Milani L
    Eur J Heart Fail; 2005 Jun; 7(4):542-51. PubMed ID: 15921793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
    Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?].
    Zieliński T
    Kardiol Pol; 2010 Jul; 68(7):779-80. PubMed ID: 20648435
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial measurements of plasma B-type natriuretic peptides: what do they tell us?
    Richards AM
    J Am Coll Cardiol; 2008 Sep; 52(12):1004-5. PubMed ID: 18786481
    [No Abstract]   [Full Text] [Related]  

  • 17. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 18. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A; Januzzi JL
    Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure.
    Huang DJ
    Chin Med J (Engl); 2009 Mar; 122(6):608-9. PubMed ID: 19323919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.